Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-221926
Filing Date
2026-05-13
Accepted
2026-05-13 17:08:07
Documents
1
Period of Report
2026-05-11

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5837
  Complete submission text file 0001193125-26-221926.txt   7622
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Issuer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INSPIRE PHARMACEUTICALS, INC. 4222 EMPEROR BLVD., SUITE 200 DURHAM NC 27703
Business Address
STAAB THOMAS R II (Reporting) CIK: 0001230708 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34600 | Film No.: 26974501